Summary

Eligibility
for people ages 1 month to 99 years (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Christine Higham, MD (ucsf)

Description

Summary

To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).

Details

Keywords

Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Stem Cell Transplant Complications, Ultrasound Elastography, Hepatic Veno-Occlusive Disease, Syndrome

Eligibility

Locations

  • University of California, San Francisco accepting new patients
    San Francisco California 94143 United States
  • Children's Mercy accepting new patients
    Kansas City Missouri 64108 United States

Lead Scientist at University of California Health

  • Christine Higham, MD (ucsf)
    Associate Professor, Pediatrics, School of Medicine. Authored (or co-authored) 23 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Children's Mercy Hospital Kansas City
ID
NCT03865589
Study Type
Interventional
Participants
Expecting 250 study participants
Last Updated